Financial results: Rua Bioscience by Martin Lane January 29, 2025January 29, 2025 New Zealand firm Rua Bioscience has achieved unaudited revenue of NZ$694k for the six months ending […]
Company news: The Entourage Effect/MedReleaf; Biortica; Medical Kiwi; Cannasouth; Rua Bioscience; Ecofibre by Martin Lane and Steve Jones December 18, 2024December 18, 2024
We’re on a journey, says Rua chair, as capital raise falls short by Steve Jones December 7, 2024December 9, 2024
Company news: Wellnex Life; Rua Bioscience; Althea by Steve Jones and Martin Lane November 6, 2024November 7, 2024
Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue by Steve Jones October 30, 2024October 30, 2024
News in brief: Drug-driving report; Rua Bioscience; Bod Science by Steve Jones October 24, 2024October 24, 2024
Rua Bioscience under pressure to raise funds but looks to ‘positive future’ by Steve Jones October 10, 2024October 10, 2024
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira by Steve Jones and Martin Lane August 28, 2024January 13, 2025
Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma by Martin Lane and Steve Jones April 16, 2024July 16, 2024